These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 13227875)

  • 21. Postpartum management of women at increased risk of thrombosis--results of a Canadian pilot survey.
    Spitzer KA; Murphy K; Crowther M; Clark CA; Laskin CA
    J Rheumatol; 2006 Nov; 33(11):2222-6. PubMed ID: 16981294
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury.
    Vergouwen MD; Roos YB; Kamphuisen PW
    Curr Opin Crit Care; 2008 Apr; 14(2):149-55. PubMed ID: 18388676
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mobilization versus immobilization in the treatment of acute proximal deep venous thrombosis: a prospective, randomized, open, multicentre trial.
    Jünger M; Diehm C; Störiko H; Hach-Wunderle V; Heidrich H; Karasch T; Ochs HR; Ranft J; Sannwald GA; Strölin A; Janssen D
    Curr Med Res Opin; 2006 Mar; 22(3):593-602. PubMed ID: 16574042
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outpatient treatment of patients with pulmonary embolism.
    Wells PS; Büller HR
    Semin Vasc Med; 2001 Nov; 1(2):229-34. PubMed ID: 15199507
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Antithrombotic prophylaxis and treatment in thrombophilic disorders in gynaecology and obstetrics].
    Dulícek P; Penka M; Binder T; Unzeitig V
    Vnitr Lek; 2006 Mar; 52 Suppl 1():58-62. PubMed ID: 16637451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thrombolysis compared with heparin for the initial treatment of pulmonary embolism: a meta-analysis of the randomized controlled trials.
    Wan S; Quinlan DJ; Agnelli G; Eikelboom JW
    Circulation; 2004 Aug; 110(6):744-9. PubMed ID: 15262836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevention effect of orally active heparin derivative on deep vein thrombosis.
    Kim SK; Lee DY; Kim CY; Moon HT; Byun Y
    Thromb Haemost; 2006 Aug; 96(2):149-53. PubMed ID: 16894457
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HEPARIN OSTEOPOROSIS.
    GRIFFITH GC; NICHOLS G; ASHER JD; FLANAGAN B
    JAMA; 1965 Jul; 193():91-4. PubMed ID: 14304374
    [No Abstract]   [Full Text] [Related]  

  • 29. Heparin and low-molecular-weight heparin.
    Gray E; Mulloy B; Barrowcliffe TW
    Thromb Haemost; 2008 May; 99(5):807-18. PubMed ID: 18449410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A review of the risks and benefits of differing prophylaxis regimens for the treatment of deep venous thrombosis and pulmonary embolism in neurosurgery.
    Epstein NE
    Surg Neurol; 2005 Oct; 64(4):295-301; discussion 302. PubMed ID: 16181995
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of obesity on outcomes after fondaparinux, enoxaparin, or heparin treatment for acute venous thromboembolism in the Matisse trials.
    Davidson BL; Büller HR; Decousus H; Gallus A; Gent M; Piovella F; Prins MH; Raskob GE; Segers AE; Lensing AW;
    J Thromb Haemost; 2007 Jun; 5(6):1191-4. PubMed ID: 17403087
    [TBL] [Abstract][Full Text] [Related]  

  • 32. What is the optimal pharmacological prophylaxis for the prevention of deep-vein thrombosis and pulmonary embolism in patients with acute ischemic stroke?
    Kamphuisen PW; Agnelli G
    Thromb Res; 2007; 119(3):265-74. PubMed ID: 16674999
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Internist patients are strongly thrombosis endangered. CERTIFY study has arrived].
    MMW Fortschr Med; 2007 May; 149(20):52-3. PubMed ID: 18051966
    [No Abstract]   [Full Text] [Related]  

  • 34. Changes of D-dimer after total hip arthroplasty in patients with and without intraoperative heparin.
    Maezawa K; Nozawa M; Aritomi K; Kubota M; Shitoto K; Kurosawa H
    Arch Orthop Trauma Surg; 2008 Jan; 128(1):37-40. PubMed ID: 17522875
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Update in the prevention and treatment of deep vein thrombosis and pulmonary embolism.
    Motsch J; Walther A; Bock M; Böttiger BW
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):52-8. PubMed ID: 16547433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Heparin-induced thrombocytopenia in hemodialysis. Case report and review of the literature].
    Henríquez F; Rodríguez A; Mora C; Sánchez-Deig E; Macía M; Navarro J
    Nefrologia; 2006; 26(6):734-7. PubMed ID: 17227252
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Low molecular weight heparin (dalteparin) is equally effective as unfractionated heparin in reducing coagulation activity and perfusion abnormalities during the early treatment of pulmonary embolism.
    Schutgens RE; Esseboom EU; Snijder RJ; Haas FJ; Verzijlbergen F; Nieuwenhuis HK; Lisman T; Biesma DH
    J Lab Clin Med; 2004 Aug; 144(2):100-7. PubMed ID: 15322504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Thromboses and embolisms of the trunk and major branches of the pulmonary artery].
    TRICOT R; NOGRETTE P
    Rev Med (Paris); 1962 Jun; 3():381-92. PubMed ID: 13922464
    [No Abstract]   [Full Text] [Related]  

  • 39. Immediate ambulation and leg compression in the treatment of deep vein thrombosis.
    Partsch H
    Dis Mon; 2005; 51(2-3):135-40. PubMed ID: 15900265
    [No Abstract]   [Full Text] [Related]  

  • 40. Low- and ultra-low-molecular-weight heparins.
    Kakkar AK
    Best Pract Res Clin Haematol; 2004 Mar; 17(1):77-87. PubMed ID: 15171959
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.